This book explores the theranostic potential of nanoerythrocytes in cancer treatment, while examining formulation strategies and technological advancements. It addresses key challenges including safety, scalability, and regulatory issues. It is useful for researchers of cancer biology, pharmaceutical sciences, and biomedical sciences.